Table 1 Clinical characteristics and expression of AIM2 between CHB group and CHC group
From: Expression of AIM2 is correlated with increased inflammation in chronic hepatitis B patients
CHB | CHC | P value | |
|---|---|---|---|
n = 47 | n = 23 | ||
Age (y) | 38.2 ± 9.0 | 37.8 ± 9.6 | 0.750 |
Male, n (%) | 30(63.8) | 14(60.9) | 0.810 |
ALT (IU/L) | 64.1 ± 40.0 | 55.5 ± 31.9 | 0.292 |
AST (IU/L) | 63.8 ± 25.0 | 58.4 ± 37.7 | 0.241 |
TB (μmol/mL) | 18.6 ± 7.7 | 26.7 ± 9.7 | 0.240 |
ALB (g/L) | 38.6 ± 11.9 | 39.8 ± 6.2 | 0.165 |
PTA (%) | 85.7 ± 10.9 | 86.3 ± 12.4 | 0.722 |
WBC (109/L) | 6.4 ± 1.8 | 6.6 ± 2.0 | 0.381 |
PLT (109/L) | 137.7 ± 51.7 | 176.3 ± 55.6 | 0.366 |
AIM2, n (%) | 42(89.4) | 2 (8.7) | 0.000 |